Skip to main content
. 2022 Aug 16;14(8):1711. doi: 10.3390/pharmaceutics14081711

Figure 11.

Figure 11

Cell viability (% control) after treatment with β–sito–Alg/Ch/NPs and β–sito–suspension at a dose ranges 10–50 µM effectively regressed the breast cancer cell line after an incubation time of 24 h (A) and 48 h (B). Data expressed as mean ± SD in triplicate (n = 3). Results estimated statistically using one way ANOVA and Tukey’s multiple comparisons test (* p < 0.05), (** p < 0.01), ns-not significant (p > 0.05) when β–sito–Alg/Ch/NPs compared with β–sito–suspension.